Zobrazeno 1 - 6
of 6
pro vyhledávání: '"D. Nesli Dolcen"'
Autor:
Suzanne D. Conzen, Balázs Györffy, Gini F. Fleming, Liewei Wang, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Geoffrey L. Greene, Larischa de Wet, Caroline R. Kim, Sarah C. Styke, Charles F. Pierce, Maxwell N. Skor, Ryan V. Harkless, Kathleen R. Bowie, Kevin J. Thompson, Jason P. Sinnwell, Ricardo R. Lastra, David J. Hosfield, D. Nesli Dolcen, Eva Y. Tonsing-Carter, Masha Kocherginsky, Diana C. West
Purpose: Although high glucocorticoid receptor (GR) expression in early-stage estrogen receptor (ER)-negative breast cancer is associated with shortened relapse-free survival (RFS), how associated GR transcriptional activity contributes to aggressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e027a72cce381dcf4648a09af62b3f
https://doi.org/10.1158/1078-0432.c.6525818.v1
https://doi.org/10.1158/1078-0432.c.6525818.v1
Autor:
Suzanne D. Conzen, Balázs Györffy, Gini F. Fleming, Liewei Wang, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Geoffrey L. Greene, Larischa de Wet, Caroline R. Kim, Sarah C. Styke, Charles F. Pierce, Maxwell N. Skor, Ryan V. Harkless, Kathleen R. Bowie, Kevin J. Thompson, Jason P. Sinnwell, Ricardo R. Lastra, David J. Hosfield, D. Nesli Dolcen, Eva Y. Tonsing-Carter, Masha Kocherginsky, Diana C. West
Graphical images of GR ChIP-seq peaks in regions flanking the TSSs of the n=31 GR putative direct target genes contained in the GRsig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b5f65c71a301a35e8499846e2f1e36
https://doi.org/10.1158/1078-0432.22464830
https://doi.org/10.1158/1078-0432.22464830
Autor:
Suzanne D. Conzen, Balázs Györffy, Gini F. Fleming, Liewei Wang, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Geoffrey L. Greene, Larischa de Wet, Caroline R. Kim, Sarah C. Styke, Charles F. Pierce, Maxwell N. Skor, Ryan V. Harkless, Kathleen R. Bowie, Kevin J. Thompson, Jason P. Sinnwell, Ricardo R. Lastra, David J. Hosfield, D. Nesli Dolcen, Eva Y. Tonsing-Carter, Masha Kocherginsky, Diana C. West
Details about the n=232 putative direct GR targets and Dex GR peaks that are loss, gained, or conserved upon addition of GR antagonists.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e61b81e89f6ce67883868a7b956200
https://doi.org/10.1158/1078-0432.22464833.v1
https://doi.org/10.1158/1078-0432.22464833.v1
Autor:
Suzanne D. Conzen, Balázs Györffy, Gini F. Fleming, Liewei Wang, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Geoffrey L. Greene, Larischa de Wet, Caroline R. Kim, Sarah C. Styke, Charles F. Pierce, Maxwell N. Skor, Ryan V. Harkless, Kathleen R. Bowie, Kevin J. Thompson, Jason P. Sinnwell, Ricardo R. Lastra, David J. Hosfield, D. Nesli Dolcen, Eva Y. Tonsing-Carter, Masha Kocherginsky, Diana C. West
Supplementary Figures, Materials and Methods, and Descriptions of Supplementary files Supplementary Figure 1. Ligand displacement of GC from GR LBD. Supplementary Figure 2. C297 monotherapy is not cytotoxic in vitro or in vivo. Supplementary Figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92e48db567b458213296fced45e7f535
https://doi.org/10.1158/1078-0432.22464827
https://doi.org/10.1158/1078-0432.22464827
Autor:
Suzanne D. Conzen, Balázs Györffy, Gini F. Fleming, Liewei Wang, Krishna R. Kalari, Matthew P. Goetz, Judy C. Boughey, Geoffrey L. Greene, Larischa de Wet, Caroline R. Kim, Sarah C. Styke, Charles F. Pierce, Maxwell N. Skor, Ryan V. Harkless, Kathleen R. Bowie, Kevin J. Thompson, Jason P. Sinnwell, Ricardo R. Lastra, David J. Hosfield, D. Nesli Dolcen, Eva Y. Tonsing-Carter, Masha Kocherginsky, Diana C. West
Patient and tumor prognostic values of study cohorts and a flow chart of the study design.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50dd9d606af620d82f77058e6aa0a0bf
https://doi.org/10.1158/1078-0432.22464836.v1
https://doi.org/10.1158/1078-0432.22464836.v1
Autor:
Jason P. Sinnwell, Gini F. Fleming, Caroline R. Kim, Ricardo R. Lastra, Ryan V. Harkless, David J. Hosfield, Diana C. West, Kevin J. Thompson, Krishna R. Kalari, Balazs Gyorffy, Judy C. Boughey, Charles F. Pierce, Maxwell N. Skor, Eva Tonsing-Carter, Masha Kocherginsky, Kathleen R. Bowie, Matthew P. Goetz, Larischa de Wet, D. Nesli Dolcen, Geoffrey L. Greene, Liewei Wang, Sarah C. Styke, Suzanne D. Conzen
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 24(14)
Purpose: Although high glucocorticoid receptor (GR) expression in early-stage estrogen receptor (ER)-negative breast cancer is associated with shortened relapse-free survival (RFS), how associated GR transcriptional activity contributes to aggressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59786039c050eed56f12b0e4cf2482bc
https://pubmed.ncbi.nlm.nih.gov/29636357
https://pubmed.ncbi.nlm.nih.gov/29636357
